YANTAI, China--(BUSINESS WIRE)--Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today releases a letter to shareholders from Hongwei Qu, Bohai’s Chairman, President and Chief Executive Officer, providing investors with management’s vision for the company in fiscal 2011.
